Navigation Links
Bell Ventures Launches Breakthrough Radical Defense Skin Care Ingredient
Date:12/8/2008

BOSTON, Dec. 8 /PRNewswire/ -- Bell Ventures LLC, a leader in innovative antioxidant solutions in food, nutrition, and skin care, announces the release of its new, high-performance natural ingredient, GlobalPAX(TM).

GlobalPAX(TM) is a proprietary extract made from the world's finest natural sources of proanthocyanidins (PACs), a powerful class of antioxidants. It is the first high-performance ingredient to standardize antioxidant capacity to Total ORAC, which analyzes antioxidant protection against 5 free radicals.

Bell Ventures also uses recognized markers of skin damage to demonstrate efficacy. GlobalPAX(TM) is standardized to collagenase and elastase inhibition, evidence that it helps defend against skin damage.

David Bell, President of Bell Ventures, says, "GlobalPAX(TM) is the result of our deep understanding of the science of antioxidants and our appreciation for their benefits to the skin. PACs are a very versatile antioxidant family, and we see this in the protection GlobalPAX(TM) delivers."

GlobalPAX(TM) provides powerful broad-spectrum defense against hydroxyl, peroxyl, peroxynitrite, singlet oxygen, and superoxide anion. Each of these radicals is implicated in skin damage.

The premium anti-aging skin care market is hungry for novel, high-performance naturals. The benefits of antioxidant protection provided by GlobalPAX(TM) make it ideal for differentiating next-generation products.

GlobalPAX(TM) has already received the attention of significant players in the industry. "We outperform a wide range of popular antioxidant ingredients, such as vitamin C, green tea extract, and green coffee cherry extract," Bell reports.

GlobalPAX(TM) can also be used to differentiate dietary supplements and the emerging category of inside-out skin care products and "beauty foods."

With standardized Total ORAC greater than 25,000 per gram, PACs, and skin outcome markers, GlobalPAX(TM) differentiates itself in a crowded market. As Bell says, "GlobalPAX(TM) lives up to its slogan, Prove what goes in before it goes on."

For more information call: 508-536-9511, email globalpax@bellventures.com, or visit http://www.globalpax.net


'/>"/>
SOURCE Bell Ventures LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Starfish Ventures Closes Australias Largest Venture Capital Fund With $185 Million Tech Fund
2. West Michigans Newest Medical Device Company Receives Support from the West Michigan Science & Technology Initiative and EDF Ventures
3. BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World
4. Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing
5. MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures
6. Oxford Finance Corporation and ATEL Ventures, Inc. Provide $7.5 Million Venture Loan to AxoGen, Inc.
7. SPO Medical Retains American Capital Ventures for Investor Relations Services
8. Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
9. The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C.
10. Clarus Ventures Closes $660 Million Fund
11. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... McLean, VA (PRWEB) , ... February 06, 2016 , ... ... enrichment session, cost-free, for middle and high school teachers on Wednesday February 10, 2016. ... be held at the Smithsonian-Mason School of Conservation, located at 1500 Remount Road in ...
(Date:2/5/2016)... 5, 2016  In the pharmaceutical industry the medical ... of launch activities including the identification and engagement of ... is especially high in the oncology therapeutic area where ... and the Role of Medical Affairs in Oncology Launch ... oncology therapies find better ways to utilize medical affairs ...
(Date:2/5/2016)... Australian-US drug discovery and development company, Novogen Limited ... a new Chairman, Mr John O,Connor , and new ... James Garner , has also been formally appointed ... CEO, Mr Iain Ross , will resume his role ... James Garner , has also been formally appointed to the ...
(Date:2/4/2016)... 4, 2016  Sangamo BioSciences, Inc. (NASDAQ: SGMO ... that Edward Lanphier , Sangamo,s president and chief ... of Sangamo,s ZFP Therapeutic ® development programs and ... pm ET on Thursday, February 11, 2016, at the ... The conference is being held in New ...
Breaking Biology Technology:
(Date:1/20/2016)... LONDON , Jan. 20, 2016 A ... positioned to directly benefit from the explosion in genomics ... from Howe Sound Research. A range of dynamic trends ... ...... - personalized medicine - pharmacogenomics - pathogen ... economies with large markets - greater understanding of the ...
(Date:1/15/2016)... Jan. 15, 2016 Recent publicized breaches in ... find new ways to ensure data security and user ... and Android that ties a user,s ... it into a hardware authorization token. Customer service agents ... fingerprint on their KodeKey enabled device to verify their ...
(Date:1/11/2016)... 11, 2016  higi, the leading retail and ... locations, web and mobile, today announced it has ... existing investors. --> ... further innovate higi,s health platform – its network ... – including expanding services and programs to retail ...
Breaking Biology News(10 mins):